A The Primary Outcome Fails — What Next?
Fulltekst
RELATERTE DOKUMENTER
The influence by the architect behind the Royal Palace, Hans Ditlev Franciscus Linstow, through the introduction of his favourite Swiss style for wooden houses, set the stage for
I Valsartan Heart Failure Trial (ValHeFT) blir valsartan eller placebo gi til pasienter som har hjertesvikt og som allerede bruker konvertasehemmere (36).. Studien Candesartan in
Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart
Background: Exercise capacity variables such as peak oxygen uptake (peakVO2) provide robust prognostic information in heart failure patients with reduced left ventricular
Despite normal left ventricular ejection fraction patients with heart failure with preserved left ventricular ejection fraction (HFpEF) present exercise intolerance which can
Evaluering av alle med hjerteinfarkt 6 - 12 uker etter utskrivelse (vurdere ICD-indikasjon) har fått klasse I-anbefaling.. Genetikk blir mer sentralt ettersom feltet er i
Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Tidsskr
I Valsartan Heart Failure Trial (ValHeFT) blir valsartan eller placebo gi til pasienter som har hjertesvikt og som allerede bruker konvertasehemmere (36).. Studien Candesartan in
